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Abstract
Primary malignant melanoma of the oesophagus is an exceedingly rare oesophageal neoplasm. It
accounts for less than 0.1% of all primary oesophageal tumours. Less than 262 cases have been
documented till today. Surgical resection with re-establishment of gastrointestinal continuity is the
treatment of choice. However, haematogenic and lymphogenic metastases are common and
despite advances in surgery, radiotherapy and chemotherapy, this tumour continues to be a highly
aggressive neoplasm with poor prognosis. The case of a 64 year-old lady with this tumour is
presented.
Background
Primary malignant melanomas of the oesophagus are
extremely rare oesophageal neoplasms and an uncom-
mon presentation of the malignant melanoma. Less than
262 cases have been described in world literature and inci-
dence figures quoted a range from 0.1 – 0.4 of all
oesophageal carcinomas [1,2].
Case Presentation
A 64 year-old Chinese female with well-controlled essen-
tial hypertension presented with a 2 month history of dys-
phagia and retrosternal discomfort and occasional blood-
tinged vomitus. This was not associated with significant
anorexia or weight loss. Digital rectal examination
revealed malaena, the rest of the physical examination
was normal and did not reveal any melanomas.
An oesophago-gastro-duodenoscopy was performed,
which revealed a large exophytic tumour at the gastric car-
dia and gastro-oesophageal junction. Histological analy-
sis of biopsy specimens from the tumour suggested the
possibility of a malignant melanoma.
A computed tomographic scan of the thorax and the
abdomen revealed the presence of irregular thickening of
the gastro-oesophageal junction which extended into the
lesser curve of the stomach. Small lymph nodes were also
seen at the coeliac axis on the CT scan. No pulmonary
lesions were noted. A whole body Tc-99m MDP bone scan
did not reveal any evidence of bone metastases. Early elec-
tive surgical resection was planned as the patient had con-
tinued to suffer from intermittent upper gastrointestinal
haemorrhage.
A subtotal oesphagectomy with proximal gastric resection
was performed with a feeding jejunostomy. The patient
was started on jejunostomy feeds on the third post-opera-
tive day to ensure early enteral nutrition. Oral feeding was
commenced by the 12th post-operative day after a gastro-
graffin swallow confirmed the absence of any leaks. The
feeding jejunostomy was removed on the 16th post-opera-
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tive day and the patient subsequently discharged the day
after.
The margins of the resected specimen were clear of malig-
nant tissue. A 5.5 cm diameter pigmented tumour nodule
located at the gastro-oesophageal junction was diagnosed
as a nodular malignant melanoma of the oesophagus
which extended into the stomach. Histologically, this
tumour was found to be composed of epitheloid cells
with pleomorphic vesicular nuclei with prominent nucle-
oli and intranuclear inclusions, eosinophilic cytoplasm
containing abundant melanin pigment, confirmed by
immunostaining with HMB 45. Two of the eight resected
peri-gastric lymph nodes contained metastatic malignant
melanoma.
Discussion
While malignant melanoma is a common skin tumour,
primary growth of this tumour in other organs is exceed-
ingly uncommon. Primary malignant melanoma occurs
twice as frequently in men as in women [1] The exception
is Japan, with more women being diagnosed than men.
The tumour most commonly occurs in the 6th and 7th dec-
ade, although younger patients have been documented as
well [3,4] The mean age of presentation is 60.5 years. It
may be found in all areas along the oesophagus, but has
been located in the lower two-thirds of the oesophagus in
86% of cases [2] No predisposing factors have been iden-
tified with certainty, but benign oesophageal melanosis is
believed to be pre-malignant [5].
From the increasing number of case reports, a fairly con-
sistent clinical presentation of such patients has emerged.
Most would complain of dysphagia, non-specific retros-
ternal pain and weight loss [6] Occasionally, haemateme-
sis and melaena, as in our patient, are observed.
Abnormal physical findings are generally absent. The
mean duration of symptoms is short, approximately 3
months.
Primary malignant melanomas of the oesophagus are
grossly polypoidal and may vary greatly in size [7] Biopsy
specimens are occasionally misdiagnosed as poorly differ-
entiated carcinoma, especially when the melanoma cells
contain few or no melanin granules. Immmunohisto-
chemical staining provides a more accurate pre-treatment
diagnosis by identifying melanocytic specific markers
such as HMB45 antibody. The exact quantification of
oesophageal tumour mass is difficult but is best judged
from the combination of endoscopic, CT scan and other
radiological techniques. Evaluation for metastatic disease
should be carried out using multiple radionucleide or CT
scans. Up to 80% of metastatic lesions are identified by
the use of technetium 99-labelled melanoma monoclonal
antigens [4] Unfortunately, 40–49% of patients will have
metastases at the time of diagnosis. The commonest sites
are the paraoesophageal lymph nodes, supraclavicular
lymph nodes, coeliac lymph nodes liver, lungs, and bones
[1].
Surgical resection in the form of a subtotal oesophagec-
tomy is the treatment of choice, with a mean survival of
14.8 months and a 5-year survival rate of 4%. [1,8] Palli-
ative limited local resection may be required to maintain
a swallowing capability and to enhance the patient's qual-
ity of life but has a mean survival of only 9 months. Other
therapeutic options such as chemotherapy, radiotherapy,
and immunotherapy provide limited benefits, even when
used in conjunction with surgery [9].
Conclusion
Primary malignant melanoma of the oesophagus is a rare
but aggressive disease, often associated with metastatic
spread at the time of presentation. Early detection, estab-
lishing a definitive diagnosis and effective treatment
remain a challenge. Radical surgical resection has
achieved the longest survival and the best prospect of a
cure. Chemotherapy and radiotherapy are mainly
deployed for palliative purposes only.
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